Skip to main content
logo
Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
1.180
+0.050 (4.42%)
At close: Apr 15, 2026, 4:00 PM EDT
1.190
+0.010 (0.85%)
After-hours: Apr 15, 2026, 4:29 PM EDT

Entera Bio Revenue

In the year 2025, Entera Bio had annual revenue of $42.00K, down -76.80%.

Revenue (ttm)
$42.00K
Revenue Growth
-76.80%
P/S Ratio
1,276.56
Revenue / Employee
$1,909
Employees
22
Market Cap
55.01M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202542.00K-139.00K-76.80%
Dec 31, 2024181.00K--
Dec 31, 2023---
Dec 31, 2022134.00K-437.00K-76.53%
Dec 31, 2021571.00K206.00K56.44%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Metagenomi Therapeutics25.21M
MindWalk Holdings20.70M
Radiopharm Theranostics10.86M
Aligos Therapeutics2.19M
ImageneBio800.00K
Mereo BioPharma Group500.00K
Revenue Rankings

ENTX News

More News